Live News Categoriesequity

Dicot Pharma AB (DICOT.ST) News

Follow Dicot Pharma AB (DICOT.ST) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol DICOT.ST Asset equity Sector Markets 90 days 1 Last 0.2156 Updated Oct 13, 2026, 07:35 AM UTC Open live news feed Open DICOT.ST chart & news

L Dicot Pharma outlines Phase 2b trial design for ED drug candidate LIB — 01 Dicot Pharma highlighted new data on its erectile-dysfunction candidate LIB-01 at the SMSNA conference. Results were already presented via three abstracts covering how the drug works, early clinical findings, and the pla NEWS | Oct 13, 2026, 07:35 AM UTC